Analysts Estimate Portillo's Inc. (PTLO) to Report a Decline in Earnings: What to Look Out for — Negative

PTLO   Zacks Investment Research — October 28, 2025

Portillo's Inc. (PTLO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Analysts Estimate Portillo's Inc. (PTLO) to Report a Decline in Earnings: What to Look Out for

Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for — Negative

QGEN   Zacks Investment Research — October 28, 2025

Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for

PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release — Positive

PTCT   Zacks Investment Research — October 28, 2025

PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Ferrari (RACE) Reports Next Week: Wall Street Expects Earnings Growth — Positive

RACE   Zacks Investment Research — October 28, 2025

Ferrari (RACE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Ferrari (RACE) Reports Next Week: Wall Street Expects Earnings Growth

Will Ultragenyx (RARE) Report Negative Q3 Earnings? What You Should Know — Negative

RARE   Zacks Investment Research — October 28, 2025

Ultragenyx (RARE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Will Ultragenyx (RARE) Report Negative Q3 Earnings? What You Should Know

uniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release — Positive

QURE   Zacks Investment Research — October 28, 2025

uniQure (QURE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news uniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Rhythm Pharmaceuticals (RYTM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Analysts Estimate Leidos (LDOS) to Report a Decline in Earnings: What to Look Out for — Negative

LDOS   Zacks Investment Research — October 28, 2025

Leidos (LDOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Analysts Estimate Leidos (LDOS) to Report a Decline in Earnings: What to Look Out for

Earnings Preview: LGI Homes (LGIH) Q3 Earnings Expected to Decline — Negative

LGIH   Zacks Investment Research — October 28, 2025

LGI Homes (LGIH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: LGI Homes (LGIH) Q3 Earnings Expected to Decline

Rivian Automotive (RIVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Positive

RIVN   Zacks Investment Research — October 28, 2025

Rivian Automotive (RIVN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Rivian Automotive (RIVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Madrigal (MDGL) Expected to Beat Earnings Estimates: Should You Buy? — Positive

MDGL   Zacks Investment Research — October 28, 2025

Madrigal (MDGL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Madrigal (MDGL) Expected to Beat Earnings Estimates: Should You Buy?

Melco Resorts (MLCO) to Report Q3 Results: Wall Street Expects Earnings Growth — Positive

MLCO   Zacks Investment Research — October 28, 2025

Melco (MLCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Melco Resorts (MLCO) to Report Q3 Results: Wall Street Expects Earnings Growth

Lumentum (LITE) Reports Next Week: Wall Street Expects Earnings Growth — Positive

LITE   Zacks Investment Research — October 28, 2025

Lumentum (LITE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Lumentum (LITE) Reports Next Week: Wall Street Expects Earnings Growth

Norwegian Cruise Line (NCLH) Reports Next Week: Wall Street Expects Earnings Growth — Positive

NCLH   Zacks Investment Research — October 28, 2025

Norwegian Cruise Line (NCLH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Norwegian Cruise Line (NCLH) Reports Next Week: Wall Street Expects Earnings Growth

Navigator Holdings (NVGS) Reports Next Week: Wall Street Expects Earnings Growth — Positive

NVGS   Zacks Investment Research — October 28, 2025

Navigator Holdings (NVGS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Navigator Holdings (NVGS) Reports Next Week: Wall Street Expects Earnings Growth

Niagen Bioscience (NAGE) Reports Next Week: What to Expect — Neutral

NAGE   Zacks Investment Research — October 28, 2025

Niagen Bioscience (NAGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Niagen Bioscience (NAGE) Reports Next Week: What to Expect

Oportun Financial (OPRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Oportun Financial Corporation (OPRT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Par Petroleum (PARR) Reports Next Week: Wall Street Expects Earnings Growth — Positive

PARR   Zacks Investment Research — October 28, 2025

Par Petroleum (PARR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Par Petroleum (PARR) Reports Next Week: Wall Street Expects Earnings Growth

Pinterest (PINS) Earnings Expected to Grow: Should You Buy? — Neutral

PINS   Zacks Investment Research — October 28, 2025

Pinterest (PINS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Pinterest (PINS) Earnings Expected to Grow: Should You Buy?

OmniAb, Inc. (OABI) Expected to Beat Earnings Estimates: Should You Buy? — Positive

OABI   Zacks Investment Research — October 28, 2025

OmniAb, Inc. (OABI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news OmniAb, Inc. (OABI) Expected to Beat Earnings Estimates: Should You Buy?